Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Chugai Pharmaceutical Co., Ltd. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 23.71%
- Healthy long term growth as Net Sales has grown by an annual rate of 11.43% and Operating profit at 19.46%
- Company has very low debt and has enough cash to service the debt requirements
2
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at JPY 464,601 MM
- DIVIDEND PER SHARE(HY) Highest at JPY 3.59
- DIVIDEND PAYOUT RATIO(Y) Highest at 211.73%
3
With ROE of 21.74%, it has a attractive valuation with a 6.45 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 24.33%, its profits have risen by 24.1% ; the PEG ratio of the company is 1.2
- At the current price, the company has a high dividend yield of 0
How much should you buy?
- Overall Portfolio exposure to Chugai Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Chugai Pharmaceutical Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Chugai Pharmaceutical Co., Ltd.
24.33%
293.87
44.16%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality key factors
Factor
Value
Sales Growth (5y)
11.43%
EBIT Growth (5y)
19.46%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.50
Sales to Capital Employed (avg)
0.69
Tax Ratio
29.16%
Dividend Payout Ratio
41.63%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
52.96%
ROE (avg)
23.71%
Valuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
6.45
EV to EBIT
19.52
EV to EBITDA
19.42
EV to Capital Employed
11.81
EV to Sales
9.30
PEG Ratio
1.23
Dividend Yield
0.01%
ROCE (Latest)
60.50%
ROE (Latest)
21.74%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at JPY 464,601 MM
DIVIDEND PER SHARE(HY)
Highest at JPY 3.59
DIVIDEND PAYOUT RATIO(Y)
Highest at 211.73%
CASH AND EQV(HY)
Highest at JPY 1,972,159 MM
OPERATING PROFIT MARGIN(Q)
Highest at 51.16 %
-2What is not working for the Company
ROCE(HY)
Lowest at 21.16%
Here's what is working for Chugai Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at JPY 464,601 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (JPY MM)
Dividend per share
Highest at JPY 3.59 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (JPY)
Operating Profit Margin
Highest at 51.16 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Cash and Eqv
Highest at JPY 1,972,159 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Dividend Payout Ratio
Highest at 211.73%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Depreciation
Highest at JPY 8,100 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)






